Abstract
SummaryMagnetic resonance imaging (MRI) of the prostate has become the gold standard for visualization of prostate cancer. Prostate MRI is usually performed as multiparametric MRI (mpMRI). Since mpMRI has several drawbacks, a biparametric MRI (bpMRI) of the prostate has been proposed. Many studies have been published on mpMRI and bpMRI in recent years. This short review offers an overview of the latest developments in this rapidly evolving field of research.
Highlights
Prostate carcinoma (PCa) is the most common cancer in men [1]
The contrast medium used for dynamic contrast-enhanced sequences (DCE) in multiparametric MRI (mpMRI) is gadolinium-based
DCE is part of the Prostate Imaging Reporting and Data System (PI-RADS) v2 guidelines [8] and is considered a cornerstone of prostatic Magnetic resonance imaging (MRI) by some authors [18], its role is controversial in the literature
Summary
Received: 28 October 2018 / Accepted: 30 October 2018 / Published online: 12 November 2018. Summary Magnetic resonance imaging (MRI) of the prostate has become the gold standard for visualization of prostate cancer. Prostate MRI is usually performed as multiparametric MRI (mpMRI). Since mpMRI has several drawbacks, a biparametric MRI (bpMRI) of the prostate has been proposed. Many studies have been published on mpMRI and bpMRI in recent years. This short review offers an overview of the latest developments in this rapidly evolving field of research. Keywords Prostatic neoplasms · Magnetic resonance imaging · Diagnostic imaging · Sensitivity and specificity · Screening
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
